Guardian Pharmacy Services (NYSE:GRDN) Shares Down 6.9% – Time to Sell?

Shares of Guardian Pharmacy Services, Inc. (NYSE:GRDN) fell 6.9% during mid-day trading on Friday . The stock traded as low as $27.70 and last traded at $27.46. 232,289 shares were traded during trading, a decline of 16% from the average session volume of 274,956 shares. The stock had previously closed at $29.50.

Analyst Ratings Changes

GRDN has been the topic of a number of research analyst reports. Weiss Ratings restated a “hold (c+)” rating on shares of Guardian Pharmacy Services in a research note on Monday, December 29th. Oppenheimer initiated coverage on Guardian Pharmacy Services in a research report on Friday, October 10th. They issued an “outperform” rating and a $30.00 target price for the company. Stephens boosted their target price on Guardian Pharmacy Services from $35.00 to $36.00 and gave the stock an “overweight” rating in a report on Wednesday. Truist Financial raised their target price on shares of Guardian Pharmacy Services from $30.00 to $34.00 and gave the stock a “buy” rating in a report on Friday, November 14th. Finally, Wall Street Zen upgraded Guardian Pharmacy Services from a “buy” rating to a “strong-buy” rating in a research report on Monday, November 17th. Four research analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the company. According to MarketBeat.com, Guardian Pharmacy Services presently has an average rating of “Moderate Buy” and a consensus target price of $32.00.

Guardian Pharmacy Services Stock Performance

The stock has a market cap of $1.71 billion, a P/E ratio of 42.75 and a beta of 0.96. The stock’s fifty day moving average is $29.99 and its 200 day moving average is $26.39.

Guardian Pharmacy Services (NYSE:GRDN) last issued its quarterly earnings data on Monday, November 10th. The company reported $0.25 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.24 by $0.01. The business had revenue of $377.43 million for the quarter, compared to the consensus estimate of $381.16 million. Guardian Pharmacy Services had a return on equity of 30.29% and a net margin of 2.90%. Equities research analysts predict that Guardian Pharmacy Services, Inc. will post 0.87 EPS for the current year.

Institutional Investors Weigh In On Guardian Pharmacy Services

Several institutional investors have recently made changes to their positions in the company. SG Americas Securities LLC boosted its holdings in Guardian Pharmacy Services by 274.9% during the 4th quarter. SG Americas Securities LLC now owns 19,017 shares of the company’s stock valued at $572,000 after acquiring an additional 13,945 shares during the period. JPMorgan Chase & Co. boosted its stake in shares of Guardian Pharmacy Services by 31.1% during the third quarter. JPMorgan Chase & Co. now owns 7,899 shares of the company’s stock valued at $207,000 after purchasing an additional 1,872 shares during the period. Voleon Capital Management LP bought a new position in shares of Guardian Pharmacy Services in the third quarter worth about $692,000. Qube Research & Technologies Ltd purchased a new position in Guardian Pharmacy Services in the 3rd quarter worth about $2,526,000. Finally, Millennium Management LLC increased its stake in Guardian Pharmacy Services by 725.2% in the 3rd quarter. Millennium Management LLC now owns 342,038 shares of the company’s stock worth $8,972,000 after buying an additional 300,587 shares during the period.

Guardian Pharmacy Services Company Profile

Guardian Pharmacy Services, Inc, a pharmacy service company, provides a suite of technology-enabled services designed to help residents of long-term health care facilities (LTCFs) in the United States. Its individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities and behavioral health facilities and group homes. The company’s Guardian Compass includes dashboards created using data from its data warehouse to help its local pharmacies plan, track, and optimize their business operations; and GuardianShield Programs for LTCFs.